Search - tctmd.com

Displaying 501 - 520 of 959

Sort: Relevancy | Date

News Daily News

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

L.A. McKeown

April 21, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

News Conference News ACC 2020

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Todd Neale

April 02, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Conference News ACC 2020

E-Cigarettes Added to Counseling Can Help Smokers Quit at 12 Weeks

Caitlin E. Cox

March 31, 2020

Presentation ACC 2020

A Randomized Controlled Trial Evaluating the Efficacy and Safety of E-Cigarettes for Smoking Cessation

Presenter: Mark Eisenberg

March 30, 2020

Presentation ACC 2020

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Presenter: Deepak L. Bhatt

March 30, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

Yael L. Maxwell

March 13, 2020

News Opinion CV Team Dispatch

March 2020 News Roundup

L.A. McKeown

March 12, 2020

News Daily News

Olive Oil Consumption Linked to CVD Benefits in the US

Shelley Wood

March 09, 2020

News Daily News

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

Todd Neale

March 05, 2020

News Conference News ISC 2020

Telehealth Program Helps Minority Stroke Survivors Control BP

Todd Neale

February 26, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Yael L. Maxwell

January 28, 2020

News Daily News

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

Yael L. Maxwell

January 16, 2020

News Daily News

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Shelley Wood

January 14, 2020

Advertisement

Smartphones Aid in Remote Monitoring of Patients With Recent Acute MI

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Evinacumab Cuts LDL Cholesterol in Homozygous FH

E-Cigarettes Added to Counseling Can Help Smokers Quit at 12 Weeks

A Randomized Controlled Trial Evaluating the Efficacy and Safety of E-Cigarettes for Smoking Cessation

EPA Levels and Cardiovascular Outcomes in the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial

Inclisiran Data in NEJM Prompt Talk of What Comes Next

AHA: Advice on Lifestyle, Risk Factor Modification to Cut A-fib Events

March 2020 News Roundup

Olive Oil Consumption Linked to CVD Benefits in the US

Habitual Use of Fish Oil Prevents CVD, Real-world Data Suggest

Telehealth Program Helps Minority Stroke Survivors Control BP

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Earlier, Longer Interventions Proposed for Optimal Population LDL Cholesterol

Coconut Oil Ups LDL Cholesterol Compared With Other Fats: Meta-analysis

CV Safety Trial for Lorcaserin Picks Up Cancer Signal: FDA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content